While BAG3 has been identified as a causative gene for dilated cardiomyopathy, the major pathological events in BAG3‐related cardiomyopathy that could be targeted for therapeutic benefit remain to be discovered. This evidence concerns the gene BAG3 and dilated cardiomyopathy.